Abstract: This invention provides isolated human antibodies and recombinant proteins comprising defined heavy chains and light chains, wherein the antibodies and recombinant proteins neutralize Andes Virus with defined IC50 values. This invention also provides related pharmaceutical compositions, treatment methods and kits.
Type:
Grant
Filed:
March 21, 2018
Date of Patent:
June 14, 2022
Assignees:
Ichor Biologies, LLC, Universidad De Concepcion
Inventors:
Maria Ines Barria, Jose Luis Garrido Ramirez, Felipe Edgardo Bravo Caceres